Chief Strategy Officer at Intermountain Healthcare; Board Chair of CivicaRx & CivicaScript; Board Chair of Graphite Health; former state senator
Utah
Joined August 2010
- Tweets 1,700
- Following 3,415
- Followers 4,096
- Likes 67
Dan Liljenquist retweeted
The work of @CivicaRx @MgVantrieste and @costplusdrugs @mcuban will have huge, positive, public health implications. -->> Civica Rx begins selling its first outpatient generic drug as it tries to overhaul the... statnews.com/pharmalot/2022/… via @statnews
Dan Liljenquist retweeted
Exciting development from @CivicaRx at same time that @costplusdrugs is rolling out HUGE price differentials.
Disruption before our eyes?!?
statnews.com/pharmalot/2022/…
Dan Liljenquist retweeted
When asked, "what's your secret sauce?" @CivicaRx's @coukell replied, "we always think of the patient first." A roundtable today on US Manufacturing & Supply Sustainability w/ US Sen @MarkWarner (VA), VA and Petersburg teams, & partners @PhlowUSA, @AmpacFineChem, @MedsforAll
Dan Liljenquist retweeted
UPDATE: @CivicaRx IS COMING THROUGH
Request for Startup: I want to fund an affordable insulin company.
Building a brand people will love will be the easy part. We'll call it: You Deserve to Live Pharmaceuticals. vox.com/2019/4/3/18293950/wh…
Dan Liljenquist retweeted
Can non-profit manufacturing solve our drug price crisis? @CivicaRx thinks so. @P4ADNow gooznews.substack.com/p/help…
Dan Liljenquist retweeted
Big development in the Diabetes world today! Our partner, @Civicarx announced plans to manufacture and distribute three insulins that will be available at a significantly lower price than insulins currently on the market. We’re excited to follow them on their journey!
We are not doing this alone…we are collaborating with partners that represent nearly every corner of the diabetes ecosystem, including the diabetes community, health systems, payers and philanthropists. #affordableinsulin
civicainsulin.org/
Dan Liljenquist retweeted
The story by @hjcarlsonk gives important details. The 3 insulins that @CivicaRx will manufacture are modern analog insulins: glargine, lispro and aspart, which will be interchangeable with Lantus, Humalog and Novolog, respectively. This is huge.
newsnetwork.mayoclinic.org/d…
Dan Liljenquist retweeted
Important to note that the prices quoted in this article for @civicarx #affordableinsulin are the maximum price to a any consumer at the pharmacy counter, not @civicarx selling price.
A group of hospitals has a plan to get around Congress’s refusal to lower the cost of insulin #diabetes #insulin #drugprices drughttps://www.washingtonpost.com/business/2022/03/03/cheaper-insulin-plan/?tid=ss_tw
Dan Liljenquist retweeted
With 1 in 4 Americans skipping doses or taking less insulin than prescribed due to the unaffordability of the prices set by today’s insulin manufacturers, @CivicaRx is meeting the moment to save lives. (4/4) jamanetwork.com/journals/jam…
Dan Liljenquist retweeted
We are thrilled to partner with you @ExcellusBCBS on this important initiative and are grateful for your support! #affordableinsulin
At Excellus BCBS, we’re committed to lowering the cost of #PrescriptionDrugs. Alongside @BCBSAssociation, we’re collaborating with @CivicaRx and other industry partners on a transformative effort to make insulin affordable for all. Learn more: bit.ly/35Fxa3F
Dan Liljenquist retweeted
.@Arnold_Ventures is helping @CivicaRx make life-sustaining insulin affordable for all. Thank you for your partnership. #affordableinsulin
With 1 in 4 Americans skipping doses or taking less insulin than prescribed due to the unaffordability of the prices set by today’s insulin manufacturers, @CivicaRx is meeting the moment to save lives. (4/4) jamanetwork.com/journals/jam…
Dan Liljenquist retweeted
As many as one quarter of insulin users skip doses or take less than prescribed amounts due to high costs, a recent study shows.
We’re proud of Utah’s own @CivicaRx for prioritizing affordable insulin, and we are excited to see this kind of innovation in health care.
Civica is thrilled to announce our plans to manufacture and distribute three insulins at significantly lower prices than insulins currently on the market, in collaboration with industry leading partners. businesswire.com/news/home/2…
Dan Liljenquist retweeted
Here you can "see" the future home of @CivicaRx affordable insulin. Thanks to the many partners who are helping to make affordable insulin a reality. #affordableinsulin @washingtonpost
Civica Rx, a nonprofit founded by a consortium of hospitals, says it will sell the insulin at a capped price of $30 per vial and $55 for five injector-pen cartridges, considerably cheaper than even the lowest-cost biosimilar insulin on the market now. wapo.st/3HE856c
Dan Liljenquist retweeted
We @Arnold_Ventures are excited to partner with @CivicaRx to manufacture and distribute generic insulin. We will break the insulin oligopoly by bringing $30 insulin to market. Patients will no longer be the victims of America's broken drug pricing system.
reuters.com/business/healthc…